Wednesday, November 05, 2014 7:26:03 PM
Quote:SNY/NVO/LLY—More on the competitive landscape in diabetes:
http://www.google.com/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CCQQFjAA&url=http%3A%2F%2Fblogs.wsj.com%2Fpharmalot%2F2014%2F10%2F28%2Fsanofi-diabetes-outlook-signals-an-undisciplined-price-war-may-erupt%2F&ei=-cBaVO7iJMyyoQT30YGoDQ&usg=AFQjCNHQD878MVZWf9c-44r6rnplMW862w&bvm=bv.78677474,d.cGU&cad=rjt
"In fact, the U.S. payer market is consolidating. Glaxo, as Moneybeat notes, estimates that the 10 largest commercial plans now control 86% of the marketplace, creating more visibility on contracting strategies and pricing. “I think you have a general shift in power toward the purchaser,” Glaxo chief executive Andrew Witty told analysts last week. Glaxo, for instance, is struggling to successfully launch its new Aroro respiratory treatment."
TRADING TNA AND TZA
http://investorshub.advfn.com/TRADING-TNA-AND-TZA-12981/
Recent LLY News
- New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis • PR Newswire (US) • 09/25/2024 10:45:00 AM
- Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease • PR Newswire (US) • 09/24/2024 10:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 08:19:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 09:19:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 09:17:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 09:11:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 09:08:44 PM
- FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis • PR Newswire (US) • 09/13/2024 08:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 08:16:25 PM
- Lilly expands manufacturing footprint in Ireland with $1.8 billion investment • PR Newswire (US) • 09/12/2024 09:30:00 AM
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes • PR Newswire (US) • 09/10/2024 03:57:00 PM
- Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes • PR Newswire (US) • 09/10/2024 03:18:00 PM
- Apple Loses EU Dispute; Google’s $2.7 Billion Fine Upheld; Oracle Shares Surge 9% • IH Market News • 09/10/2024 10:02:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 11:03:46 AM
- Lilly appoints Lucas Montarce as executive vice president and chief financial officer • PR Newswire (US) • 09/09/2024 10:45:00 AM
- In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin • PR Newswire (US) • 09/05/2024 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 08:05:08 PM
- Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries • PR Newswire (US) • 09/04/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:05:08 PM
- High Volatility Expected in Nvidia Report, Ambarella Soars 20%, Hertz Strengthens Board, Apple Cuts Jobs • IH Market News • 08/28/2024 09:50:36 AM
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity • PR Newswire (US) • 08/27/2024 10:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:47:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 08:21:53 PM
- IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts • IH Market News • 08/26/2024 12:58:21 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM